These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34794002)

  • 21. Design and synthesis of novel site-specific antibody-drug conjugates that target TROP2.
    Luo C; Ren A; Jin Z; Zhang J; Shi W; Zeng Y; Liu Z; Lu M; Hou Y; Tang F; Huang W
    Bioorg Med Chem; 2024 Aug; 110():117828. PubMed ID: 38981219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of a PEGylated Glucuronide-Monomethylauristatin E Linker for Antibody-Drug Conjugates.
    Burke PJ; Hamilton JZ; Jeffrey SC; Hunter JH; Doronina SO; Okeley NM; Miyamoto JB; Anderson ME; Stone IJ; Ulrich ML; Simmons JK; McKinney EE; Senter PD; Lyon RP
    Mol Cancer Ther; 2017 Jan; 16(1):116-123. PubMed ID: 28062707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecularly Engineering Triptolide with Aptamers for High Specificity and Cytotoxicity for Triple-Negative Breast Cancer.
    He J; Peng T; Peng Y; Ai L; Deng Z; Wang XQ; Tan W
    J Am Chem Soc; 2020 Feb; 142(6):2699-2703. PubMed ID: 31910009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. XPB, a subunit of TFIIH, is a target of the natural product triptolide.
    Titov DV; Gilman B; He QL; Bhat S; Low WK; Dang Y; Smeaton M; Demain AL; Miller PS; Kugel JF; Goodrich JA; Liu JO
    Nat Chem Biol; 2011 Mar; 7(3):182-8. PubMed ID: 21278739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads.
    Nakada T; Masuda T; Naito H; Yoshida M; Ashida S; Morita K; Miyazaki H; Kasuya Y; Ogitani Y; Yamaguchi J; Abe Y; Honda T
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1542-1545. PubMed ID: 26898815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the effects of linker composition on site-specifically modified antibody-drug conjugates.
    Albers AE; Garofalo AW; Drake PM; Kudirka R; de Hart GW; Barfield RM; Baker J; Banas S; Rabuka D
    Eur J Med Chem; 2014 Dec; 88():3-9. PubMed ID: 25176286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and Validation of Linkers for Site-Specific Preparation of Antibody-Drug Conjugates Carrying Multiple Drug Copies Per Cysteine Conjugation Site.
    Kumar A; Mao S; Dimasi N; Gao C
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semisynthesis of C-ring modified triptolide analogues and their cytotoxic activities.
    Aoyagi Y; Hitotsuyanagi Y; Hasuda T; Fukaya H; Takeya K; Aiyama R; Matsuzaki T; Hashimoto S
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1947-9. PubMed ID: 16455242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aptamer-functionalized triptolide with release controllability as a promising targeted therapy against triple-negative breast cancer.
    Chen Y; Yang J; Wang C; Wang T; Zeng Y; Li X; Zuo Y; Chen H; Zhang C; Cao Y; Sun C; Wang M; Cao X; Ge X; Liu Y; Zhang G; Deng Y; Peng C; Lu A; Lu J
    J Exp Clin Cancer Res; 2024 Jul; 43(1):207. PubMed ID: 39054545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunochemical characterization of the functional constituents of Tripterygium wilfordii contributing to its anti-inflammatory property.
    Wong KF; Chan JK; Chan KL; Tam P; Yang D; Fan ST; Luk JM
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):55-9. PubMed ID: 18047628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma.
    Ling D; Xia H; Park W; Hackett MJ; Song C; Na K; Hui KM; Hyeon T
    ACS Nano; 2014 Aug; 8(8):8027-39. PubMed ID: 25093274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzymatic conjugation using branched linkers for constructing homogeneous antibody-drug conjugates with high potency.
    Anami Y; Xiong W; Gui X; Deng M; Zhang CC; Zhang N; An Z; Tsuchikama K
    Org Biomol Chem; 2017 Jul; 15(26):5635-5642. PubMed ID: 28649690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bis(vinylsulfonyl)piperazines as efficient linkers for highly homogeneous antibody-drug conjugates.
    Huang R; Sheng Y; Wei D; Yu J; Chen H; Jiang B
    Eur J Med Chem; 2020 Mar; 190():112080. PubMed ID: 32018094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of novel C14-hydroxyl substituted triptolide derivatives as potential selective antitumor agents.
    Li Z; Zhou ZL; Miao ZH; Lin LP; Feng HJ; Tong LJ; Ding J; Li YC
    J Med Chem; 2009 Aug; 52(16):5115-23. PubMed ID: 19637874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion.
    Dimasi N; Fleming R; Zhong H; Bezabeh B; Kinneer K; Christie RJ; Fazenbaker C; Wu H; Gao C
    Mol Pharm; 2017 May; 14(5):1501-1516. PubMed ID: 28245132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and structure-activity relationships studies on the D ring of the natural product triptolide.
    Xu H; Tang H; Feng H; Li Y
    ChemMedChem; 2014 Feb; 9(2):290-5. PubMed ID: 24339424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triptolide Suppresses Growth of Breast Cancer by Targeting HMGB1 in Vitro and in Vivo.
    Jiang W; Chen M; Xiao C; Yang W; Qin Q; Tan Q; Liang Z; Liao X; Mao A; Wei C
    Biol Pharm Bull; 2019 Jun; 42(6):892-899. PubMed ID: 30956264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms.
    Zhou ZL; Yang YX; Ding J; Li YC; Miao ZH
    Nat Prod Rep; 2012 Apr; 29(4):457-75. PubMed ID: 22270059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diazaborines Are a Versatile Platform to Develop ROS-Responsive Antibody Drug Conjugates*.
    António JPM; Carvalho JI; André AS; Dias JNR; Aguiar SI; Faustino H; Lopes RMRM; Veiros LF; Bernardes GJL; da Silva FA; Gois PMP
    Angew Chem Int Ed Engl; 2021 Dec; 60(49):25914-25921. PubMed ID: 34741376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triptolide derivatives as potential multifunctional anti-Alzheimer agents: Synthesis and structure-activity relationship studies.
    Ning C; Mo L; Chen X; Tu W; Wu J; Hou S; Xu J
    Bioorg Med Chem Lett; 2018 Feb; 28(4):689-693. PubMed ID: 29366650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.